These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 19954924)

  • 1. Synergistic anticancer effects of combined gamma-tocotrienol and celecoxib treatment are associated with suppression in Akt and NFkappaB signaling.
    Shirode AB; Sylvester PW
    Biomed Pharmacother; 2010 May; 64(5):327-32. PubMed ID: 19954924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced antiproliferative and apoptotic response to combined treatment of gamma-tocotrienol with erlotinib or gefitinib in mammary tumor cells.
    Bachawal SV; Wali VB; Sylvester PW
    BMC Cancer; 2010 Mar; 10():84. PubMed ID: 20211018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined treatment of gamma-tocotrienol with statins induce mammary tumor cell cycle arrest in G1.
    Wali VB; Bachawal SV; Sylvester PW
    Exp Biol Med (Maywood); 2009 Jun; 234(6):639-50. PubMed ID: 19359655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synergistic antiproliferative effects of gamma-tocotrienol and statin treatment on mammary tumor cells.
    Wali VB; Sylvester PW
    Lipids; 2007 Dec; 42(12):1113-23. PubMed ID: 17701065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gamma-tocotrienol inhibits neoplastic mammary epithelial cell proliferation by decreasing Akt and nuclear factor kappaB activity.
    Shah SJ; Sylvester PW
    Exp Biol Med (Maywood); 2005 Apr; 230(4):235-41. PubMed ID: 15792944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression in mevalonate synthesis mediates antitumor effects of combined statin and gamma-tocotrienol treatment.
    Wali VB; Bachawal SV; Sylvester PW
    Lipids; 2009 Oct; 44(10):925-34. PubMed ID: 19777282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms Mediating the Synergistic Anticancer Effects of Combined γ-Tocotrienol and Celecoxib Treatment.
    Shirode AB; Sylvester PW
    J Bioanal Biomed; 2011 Jan; 3():1-7. PubMed ID: 22140606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. gamma-Tocotrienol inhibits ErbB3-dependent PI3K/Akt mitogenic signalling in neoplastic mammary epithelial cells.
    Samant GV; Sylvester PW
    Cell Prolif; 2006 Dec; 39(6):563-74. PubMed ID: 17109639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sesamin synergistically potentiates the anticancer effects of γ-tocotrienol in mammary cancer cell lines.
    Akl MR; Ayoub NM; Abuasal BS; Kaddoumi A; Sylvester PW
    Fitoterapia; 2013 Jan; 84():347-59. PubMed ID: 23266736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms mediating the synergistic anticancer effects of combined γ-tocotrienol and sesamin treatment.
    Akl MR; Ayoub NM; Sylvester PW
    Planta Med; 2012 Nov; 78(16):1731-9. PubMed ID: 22987298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synergistic anticancer effects of combined γ-tocotrienol and oridonin treatment is associated with the induction of autophagy.
    Tiwari RV; Parajuli P; Sylvester PW
    Mol Cell Biochem; 2015 Oct; 408(1-2):123-37. PubMed ID: 26112904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined gamma-tocotrienol and erlotinib/gefitinib treatment suppresses Stat and Akt signaling in murine mammary tumor cells.
    Bachawal SV; Wali VB; Sylvester PW
    Anticancer Res; 2010 Feb; 30(2):429-37. PubMed ID: 20332450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intracellular signaling mechanisms mediating the antiproliferative and apoptotic effects of gamma-tocotrienol in neoplastic mammary epithelial cells.
    Sylvester PW; Shah SJ; Samant GV
    J Plant Physiol; 2005 Jul; 162(7):803-10. PubMed ID: 16008108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tocotrienol-induced caspase-8 activation is unrelated to death receptor apoptotic signaling in neoplastic mammary epithelial cells.
    Shah S; Sylvester PW
    Exp Biol Med (Maywood); 2004 Sep; 229(8):745-55. PubMed ID: 15337828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. γ-Tocotrienol inhibits HGF-dependent mitogenesis and Met activation in highly malignant mammary tumour cells.
    Ayoub NM; Bachawal SV; Sylvester PW
    Cell Prolif; 2011 Dec; 44(6):516-26. PubMed ID: 21973114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of angiotensin II activity enhanced the antitumor effect of cyclooxygenase-2 inhibitors via insulin-like growth factor I receptor pathway.
    Yasumaru M; Tsuji S; Tsujii M; Irie T; Komori M; Kimura A; Nishida T; Kakiuchi Y; Kawai N; Murata H; Horimoto M; Sasaki Y; Hayashi N; Kawano S; Hori M
    Cancer Res; 2003 Oct; 63(20):6726-34. PubMed ID: 14583467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined γ-tocotrienol and Met inhibitor treatment suppresses mammary cancer cell proliferation, epithelial-to-mesenchymal transition and migration.
    Ayoub NM; Akl MR; Sylvester PW
    Cell Prolif; 2013 Oct; 46(5):538-53. PubMed ID: 24033536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tocotrienols target PI3K/Akt signaling in anti-breast cancer therapy.
    Sylvester PW; Ayoub NM
    Anticancer Agents Med Chem; 2013 Sep; 13(7):1039-47. PubMed ID: 23272909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination effects of salvianolic acid B with low-dose celecoxib on inhibition of head and neck squamous cell carcinoma growth in vitro and in vivo.
    Zhao Y; Hao Y; Ji H; Fang Y; Guo Y; Sha W; Zhou Y; Pang X; Southerland WM; Califano JA; Gu X
    Cancer Prev Res (Phila); 2010 Jun; 3(6):787-96. PubMed ID: 20501859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of Rac1/WAVE2 Signaling in Mediating the Inhibitory Effects of γ-Tocotrienol on Mammary Cancer Cell Migration and Invasion.
    Algayadh IG; Dronamraju V; Sylvester PW
    Biol Pharm Bull; 2016; 39(12):1974-1982. PubMed ID: 27904039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.